Skip to content

Milk in Life Conditions (MiLC): Bacterial Composition of Human Milk Pumped and Stored in Real-Life Conditions

Milk in Life Conditions (MiLC): Characterizing the Bacterial Composition of Human Milk Pumped and Stored in Real-life Conditions

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03123874
Acronym
MiLC
Enrollment
52
Registered
2017-04-21
Start date
2017-05-22
Completion date
2017-10-02
Last updated
2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial Growth, Human Milk Microbiome

Keywords

human milk, breast milk, expressed human milk, bacterial communities, microbiome, breast pump, bacterial growth

Brief summary

The MiLC trial is a randomized control trial of two different breast pump set-ups: mother's own and sterile. The objective of this trial is to investigate the bacterial composition of human milk pumped and stored in real-life conditions. To meet this objective, lactating mothers will fully express breast milk from one breast on two consecutive pumping sessions at home, once with the participant's own pumps and collection kits (own pump set-up) and once with a hospital-grade pump and disposable, sterile collection kits (sterile pump set-up). Randomization will be used to determine which pump participants use first. From the total volume of milk pumped during each pumping session, the researchers will collect 1 oz. Milk from both pumps will be stored at home and sampled on days 0, 2, 4, and 30 after expression for analysis of its bacterial composition.

Detailed description

Participants will donate 1 oz of human milk during each of two consecutive pumping sessions, for a total volume of 2 oz donated on one day. To collect this human milk, participants will be asked to fully express one breast during each pumping session. Participants will pump once with the participant's own pump set-up and once with the sterile pump set-up (provided by the research team). Women will be randomized to which pump is used first. Randomization will be done using stratified randomization as follows: participants were stratified by how their infants were fed, namely whether infants were fed human milk only vs. human milk and complementary foods). Then, randomization was conducted within each strata. The researchers aim to have a minimum of 25 participants in each stratum. All human milk collections will occur at participants' homes between 0700 and 1100 hours. The second pumping session must begin 3 hours (+/-30 minutes) after the beginning of the first pumping session (e.g. the first pumping session at 7:30 am and the second at 10:30 am). Participants will elect from which breast to donate human milk and that breast will be used for both pumping sessions. Participants will be asked not to nurse from or pump that breast during the 2 hours before the first pumping session and not until after the second pumping session (a total of \ 5.5 hours). From the milk produced during each pumping session (which could be up to \ 6 oz), researchers will collect 1 oz using a sterile, plastic syringe. Participants will keep the remaining volume of milk. Each ounce of milk collected will be separated into 5 sterile containers (provided). Participants will store donated milk at home until it is picked up by a researcher 2, 4, and 30 days after pumping.

Interventions

DEVICESterile pump set-up

Medela symphony breast pump (model number 0240108) and disposable, sterile collection kits (model number 67399S).

DEVICEMother's Own pump set-up

Mother's own electric breast pump and own collection kit (previously used and cleaned at home using her usual practices).

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
University of Idaho
CollaboratorOTHER
United States Department of Agriculture (USDA)
CollaboratorFED
Cornell University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

All participants will pump their milk with two pump set-ups: own and sterile supplies. The pump set-up each woman used first was randomized according to infant feeding status (human milk only vs. human milk and complementary foods).

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Lactating women over the age of 18 years * Self-reported as healthy women and infants * Use an electric breast pump * Confident of ability to donate 1 oz of milk from one breast during each of two consecutive pumping sessions where pumping sessions are 3 hours (+/- 30 minutes) apart and between 0700-1100 hours. * Able to store donated milk at home for 30 days * Have infants who do not consume formula or only consume formula episodically as long as the most recent formula-feeding occurred \> 2 weeks before the day milk is pumped for this study.

Exclusion criteria

* Not confident of ability to donate 1 oz of milk from one breast during each of two consecutive pumping sessions, 3 hours (+/- 30 minutes) apart and between the hours of 0700-1100 hours. * Infant consumption of formula in the past 2 weeks * Current indication of breast infection (e.g., breast pain, discomfort, lumps, mastitis with fever, red streaks, or hard red portions of the breast) * Breast pain that the woman does not consider normal for lactation/breastfeeding * Signs/symptoms of acute illness in woman or infant in past 7 days including fever (rectal or temporal temperature ≥99.5 F), dark green nasal discharge, diarrhea (abrupt onset of 3 or more excessively loose stools in one day), vomiting (where infant vomiting is not associated with feeding), or severe cough.

Design outcomes

Primary

MeasureTime frameDescription
Bacterial Community Richness0 days after pumpingRichness is the total number of different bacterial taxa detected in the sample. This metric will be assessed on data collected via high-throughput sequencing of the bacterial 16S rRNA gene present in milk.
Bacterial Community Diversity0 days after pumpingBacterial community diversity will be assessed using the the Shannon diversity index. The Shannon diversity index is a type of entropy measure and is a function of the distribution of the total number of organisms across all of the species. If S is the total number of species in the sample and p\_i is the number of organisms in the i-th species divided by the total number of organisms, then Diversity = -Σ p\_i log(p\_i). This metric will be assessed on data collected via high-throughput sequencing of the bacterial 16S rRNA gene present in milk.
Total Live Aerobic Bacterial Counts0 days after pumpingNumber of live total aerobic bacteria in milk assessed by aerobic culturing of milk on plate count agar. Reported as colony-forming units (CFU)/mL.

Countries

United States

Participant flow

Participants by arm

ArmCount
Sterile Pump Set-up First
Participants will pump with sterile pump set-ups first. Approximately 3 hours later, participants will pump with their own pump set-ups.
27
Mother's Own Pump Set-up First
Participants will pump with their own pump set-ups first. Approximately 3 hours later, participants will pump with sterile pump set-ups.
25
Total52

Baseline characteristics

CharacteristicSterile Pump Set-up FirstMother's Own Pump Set-up FirstTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
27 Participants25 Participants52 Participants
Age, Continuous33.6 years
STANDARD_DEVIATION 4.1
33.6 years
STANDARD_DEVIATION 4
33.6 years
STANDARD_DEVIATION 4
Infant feeding status, number fed human milk only13 Participants14 Participants27 Participants
Race/Ethnicity, Customized
African American/black
0 Participants1 Participants1 Participants
Race/Ethnicity, Customized
Asian or Pacific Islander
2 Participants1 Participants3 Participants
Race/Ethnicity, Customized
Caucasian/white
23 Participants22 Participants45 Participants
Race/Ethnicity, Customized
Native American
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Other
0 Participants2 Participants2 Participants
Region of Enrollment
United States
27 participants25 participants52 participants
Sex: Female, Male
Female
27 Participants25 Participants52 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Bacterial Community Diversity

Bacterial community diversity will be assessed using the the Shannon diversity index. The Shannon diversity index is a type of entropy measure and is a function of the distribution of the total number of organisms across all of the species. If S is the total number of species in the sample and p\_i is the number of organisms in the i-th species divided by the total number of organisms, then Diversity = -Σ p\_i log(p\_i). This metric will be assessed on data collected via high-throughput sequencing of the bacterial 16S rRNA gene present in milk.

Time frame: 0 days after pumping

Population: Data analyzed from all participants.

ArmMeasureGroupValue (MEAN)Dispersion
Sterile Pump Set-up FirstBacterial Community DiversityIn Milk Collected with Sterile Pump Set-Up3.89 Shannon Diversity IndexStandard Deviation 1.18
Sterile Pump Set-up FirstBacterial Community DiversityIn Milk Collected with Mother's Own Pump Set-Up3.84 Shannon Diversity IndexStandard Deviation 1.08
Mother's Own Pump Set-up FirstBacterial Community DiversityIn Milk Collected with Sterile Pump Set-Up3.56 Shannon Diversity IndexStandard Deviation 1.13
Mother's Own Pump Set-up FirstBacterial Community DiversityIn Milk Collected with Mother's Own Pump Set-Up3.93 Shannon Diversity IndexStandard Deviation 1.26
p-value: 0.3Mixed Models Analysis
Primary

Bacterial Community Richness

Richness is the total number of different bacterial taxa detected in the sample. This metric will be assessed on data collected via high-throughput sequencing of the bacterial 16S rRNA gene present in milk.

Time frame: 0 days after pumping

Population: Data analyzed for all participants

ArmMeasureGroupValue (MEAN)Dispersion
Sterile Pump Set-up FirstBacterial Community RichnessIn Milk Collected with Sterile Pump Set-Up64.2 Observed taxaStandard Deviation 38.3
Sterile Pump Set-up FirstBacterial Community RichnessIn Milk Collected with Mother's Own Pump Set-Up64.0 Observed taxaStandard Deviation 30.7
Mother's Own Pump Set-up FirstBacterial Community RichnessIn Milk Collected with Sterile Pump Set-Up58.9 Observed taxaStandard Deviation 26.9
Mother's Own Pump Set-up FirstBacterial Community RichnessIn Milk Collected with Mother's Own Pump Set-Up60.8 Observed taxaStandard Deviation 32.8
p-value: 0.9Mixed Models Analysis
Primary

Total Live Aerobic Bacterial Counts

Number of live total aerobic bacteria in milk assessed by aerobic culturing of milk on plate count agar. Reported as colony-forming units (CFU)/mL.

Time frame: 0 days after pumping

Population: Data for all participants analyzed.

ArmMeasureGroupValue (GEOMETRIC_MEAN)Dispersion
Sterile Pump Set-up FirstTotal Live Aerobic Bacterial CountsIn Milk Collected with Sterile Pump Set-Up1848 Colony-forming units (CFU)/mLStandard Deviation 734
Sterile Pump Set-up FirstTotal Live Aerobic Bacterial CountsIn Milk Collected with Mother's Own Pump Set-Up9157 Colony-forming units (CFU)/mLStandard Deviation 3638
Mother's Own Pump Set-up FirstTotal Live Aerobic Bacterial CountsIn Milk Collected with Sterile Pump Set-Up1233 Colony-forming units (CFU)/mLStandard Deviation 490
Mother's Own Pump Set-up FirstTotal Live Aerobic Bacterial CountsIn Milk Collected with Mother's Own Pump Set-Up6109 Colony-forming units (CFU)/mLStandard Deviation 2427
p-value: 0.0003Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026